Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Injectable cabotegravir and rilpivirine are approved for people with viral suppression who would prefer monthly injections to daily pills.
Injectable cabotegravir and rilpivirine are approved for people with viral suppression who want monthly injections instead of daily pills.
The European Medicines Agency gave the green light to injectable cabotegravir and rilpivirine for HIV treatment.
The FDA recently held up the U.S. approval based on concerns over the monthly injectable regimen’s manufacturing.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.